Reduction in allogeneic blood. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy25

T-Lymphocytes Spleen Dendritic Cells Lymphocytes T-Lymphocytes, Cytotoxic CD4-Positive T-Lymphocytes Killer Cells, Natural Allografts CD8-Positive T-Lymphocytes Cells, Cultured Antilymphocyte Serum T-Lymphocytes, Regulatory Bone Marrow Cells Thymus Gland Bone Marrow B-Lymphocytes T-Lymphocyte Subsets Hematopoietic Stem Cells Antigen-Presenting Cells Clone Cells Blood Cells Monocytes Fetal Blood Lymph Nodes Antibody-Producing Cells

Organisms13

Transplantation Chimera Mice, Inbred BALB C Mice, Inbred C57BL Radiation Chimera Mice, Inbred Strains Mice, Inbred C3H Chimera Mice, Inbred DBA Cytomegalovirus Mice, Inbred CBA Mice, Inbred AKR Rats, Inbred Lew Mice, SCID

Diseases35

Blood Loss, Surgical Graft vs Host Disease Postoperative Hemorrhage Leukemia Surgical Wound Dehiscence Recurrence Hematologic Neoplasms Leukemia, Myeloid, Acute Leukemia, Myelogenous, Chronic, BCR-ABL Positive Precursor Cell Lymphoblastic Leukemia-Lymphoma Anemia, Aplastic Acute Disease Myelodysplastic Syndromes Cytomegalovirus Infections Hematologic Diseases Hepatic Veno-Occlusive Disease Leukemia, Myeloid Multiple Myeloma Neoplasm, Residual Lymphoma Chronic Disease Infection Lymphoma, Non-Hodgkin Sarcoma, Experimental Lymphoproliferative Disorders Mycoses Primary Myelofibrosis Aspergillosis Opportunistic Infections Leukemia, Lymphocytic, Chronic, B-Cell Cystitis Blood Group Incompatibility Leukemia, Myeloid, Accelerated Phase Anemia, Refractory, with Excess of Blasts Mast-Cell Sarcoma

Chemicals and Drugs51

Aprotinin Aminocaproates Antifibrinolytic Agents Hemostatics Vidarabine Granulocyte Colony-Stimulating Factor Immunosuppressive Agents Hemoglobins Isoantigens Busulfan Myeloablative Agonists HLA Antigens Histocompatibility Antigens H-2 Antigens Minor Histocompatibility Antigens Cyclophosphamide Antilymphocyte Serum Antigens, CD Cyclosporine Interleukin-2 Isoantibodies Antibodies, Monoclonal Interferon-gamma Ganciclovir Antigens, CD3 Histocompatibility Antigens Class II Cytokines Antigens, Neoplasm Antigens, CD34 Histocompatibility Antigens Class I Antibodies, Neoplasm Antigens, CD80 Cancer Vaccines Antigens, CD8 Concanavalin A CD40 Ligand Antigens, Differentiation, T-Lymphocyte Antigens, Surface Cytarabine Membrane Glycoproteins Antigens Tacrolimus Melphalan Epitopes Methotrexate Antigens, CD86 Immunoconjugates Receptors, Antigen, T-Cell Antineoplastic Agents Granulocyte-Macrophage Colony-Stimulating Factor HLA-DR Antigens

Analytical, Diagnostic and Therapeutic Techniques and Equipment72

Blood Transfusion, Autologous Blood Transfusion Operative Blood Salvage Transplantation, Homologous Hemodilution Hematopoietic Stem Cell Transplantation Erythrocyte Transfusion Bone Marrow Transplantation Perioperative Care Transplantation Conditioning Platelet Transfusion Blood Component Transfusion Intraoperative Care Thrombelastography Histocompatibility Testing Preoperative Care Treatment Outcome Cardiac Surgical Procedures Hematocrit Arthroplasty, Replacement, Knee Prospective Studies Arthroplasty, Replacement, Hip Life Tables Retrospective Studies Lymphocyte Culture Test, Mixed Anesthesia Survival Rate Transplantation, Isogeneic Whole-Body Irradiation Stem Cell Transplantation Follow-Up Studies Skin Transplantation Risk Factors Transplantation, Autologous Lymphocyte Activation Lymphocyte Depletion Immunosuppression Remission Induction Leukocyte Transfusion Peripheral Blood Stem Cell Transplantation Survival Analysis Cytotoxicity Tests, Immunologic Immunotherapy, Adoptive Flow Cytometry Graft Enhancement, Immunologic Combined Modality Therapy Immunophenotyping Islets of Langerhans Transplantation Salvage Therapy Immunotherapy Cell Separation Coculture Techniques Hematopoietic Stem Cell Mobilization Cord Blood Stem Cell Transplantation Corneal Transplantation Antineoplastic Combined Chemotherapy Protocols Actuarial Analysis Sarcoma, Experimental Cell Transplantation Transplantation, Heterotopic Leukocyte Count Adoptive Transfer Heart Transplantation Prognosis Leukapheresis Lymphocyte Count Fatal Outcome Blood Component Removal Neoplasm Transplantation Thymectomy Blood Grouping and Crossmatching Polymerase Chain Reaction

Psychiatry and Psychology2

Siblings Nuclear Family

Phenomena and Processes32

Graft Survival Hematocrit Graft vs Tumor Effect Graft vs Leukemia Effect Histocompatibility Graft vs Host Reaction Lymphocyte Activation Graft Rejection Transplantation Immunology Cytotoxicity, Immunologic Radiation Chimera Immune Tolerance Chimerism Transplantation Tolerance Time Factors Major Histocompatibility Complex Immunity, Cellular Host vs Graft Reaction Lymphocyte Cooperation Antibody Formation Virus Activation Cell Differentiation Leukocyte Count Hematopoiesis Immunocompromised Host Lymphocyte Count Antigen Presentation Cell Proliferation Dose-Response Relationship, Immunologic Cell Division Immunologic Memory Phenotype

Anthropology, Education, Sociology and Social Phenomena2

Siblings Nuclear Family

Information Science3

Life Tables Survival Rate Fatal Outcome

Named Groups4

Blood Donors Tissue Donors Siblings Unrelated Donors

Health Care13

Perioperative Care Intraoperative Care Preoperative Care Treatment Outcome Prospective Studies Life Tables Retrospective Studies Survival Rate Follow-Up Studies Risk Factors Survival Analysis Actuarial Analysis Fatal Outcome

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care

Blood Transfusion, Autologous Blood Transfusion Operative Blood Salvage Transplantation, Homologous Blood Loss, Surgical Hemodilution Hematopoietic Stem Cell Transplantation Erythrocyte Transfusion Graft vs Host Disease Bone Marrow Transplantation Perioperative Care Transplantation Conditioning Transplantation Chimera Postoperative Hemorrhage Platelet Transfusion Aprotinin Aminocaproates Antifibrinolytic Agents Blood Component Transfusion Intraoperative Care Thrombelastography Histocompatibility Testing Hemostatics Preoperative Care Leukemia Blood Donors Vidarabine Treatment Outcome Graft Survival Surgical Wound Dehiscence Cardiac Surgical Procedures Hematocrit Arthroplasty, Replacement, Knee Recurrence Granulocyte Colony-Stimulating Factor Immunosuppressive Agents Prospective Studies Hemoglobins Arthroplasty, Replacement, Hip Life Tables Retrospective Studies Isoantigens Lymphocyte Culture Test, Mixed Hematologic Neoplasms Graft vs Tumor Effect T-Lymphocytes Anesthesia Survival Rate Transplantation, Isogeneic Whole-Body Irradiation Graft vs Leukemia Effect Stem Cell Transplantation Tissue Donors Follow-Up Studies Skin Transplantation Risk Factors Histocompatibility Graft vs Host Reaction Transplantation, Autologous Lymphocyte Activation Busulfan Graft Rejection Transplantation Immunology Cytotoxicity, Immunologic Mice, Inbred BALB C Mice, Inbred C57BL Lymphocyte Depletion Immunosuppression Remission Induction Spleen Leukemia, Myeloid, Acute Myeloablative Agonists Leukemia, Myelogenous, Chronic, BCR-ABL Positive Radiation Chimera Leukocyte Transfusion Peripheral Blood Stem Cell Transplantation Dendritic Cells Immune Tolerance Precursor Cell Lymphoblastic Leukemia-Lymphoma Anemia, Aplastic HLA Antigens Lymphocytes Acute Disease Chimerism T-Lymphocytes, Cytotoxic Transplantation Tolerance Histocompatibility Antigens Myelodysplastic Syndromes Mice, Inbred Strains Time Factors Cytomegalovirus Infections Mice, Inbred C3H H-2 Antigens Survival Analysis Cytotoxicity Tests, Immunologic CD4-Positive T-Lymphocytes Immunotherapy, Adoptive Killer Cells, Natural Allografts Minor Histocompatibility Antigens

No FAQ available that match "reduction in allogeneic blood"